These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7280115)

  • 21. Failure of prostaglandin F2 alpha analogue to induce luteolysis in GnRH agonist treated heifers.
    Birnie LM; Broadbent PJ; Hutchinson JS
    Vet Rec; 1997 Mar; 140(12):315. PubMed ID: 9106966
    [No Abstract]   [Full Text] [Related]  

  • 22. The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
    Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
    J Pharm Pharmacol; 1978 Sep; 30(9):597-9. PubMed ID: 29109
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of prostaglandins on the bovine corpus luteum: granules, lipid inclusions and progesterone secretion.
    Heath E; Weinstein P; Merritt B; Shanks R; Hixon J
    Biol Reprod; 1983 Nov; 29(4):977-85. PubMed ID: 6315098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization and identification of EP3 prostanoid receptor binding sites in hamster uterus homogenates.
    Sharif NA; Xu SX
    J Pharm Pharmacol; 2004 Feb; 56(2):197-203. PubMed ID: 15005878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
    Dong YJ; Jones RL; Wilson NH
    Br J Pharmacol; 1986 Jan; 87(1):97-107. PubMed ID: 2420404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Luteolytic potency of PGD and PGF2 alpha derivatives.
    Brambaifa N
    Eur J Obstet Gynecol Reprod Biol; 1988 Apr; 27(4):319-25. PubMed ID: 3164283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations.
    Jones RL; Wilson NH
    Adv Prostaglandin Thromboxane Res; 1980; 6():467-75. PubMed ID: 7386280
    [No Abstract]   [Full Text] [Related]  

  • 28. Secondary pharmacological properties of prostaglandins.
    Jackson PS; Jessup R
    Vet Rec; 1984 Feb; 114(7):168. PubMed ID: 6587657
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and platelet aggregation inhibiting activity of prostaglandin D analogues.
    Bundy GL; Morton DR; Peterson DC; Nishizawa EE; Miller WL
    J Med Chem; 1983 Jun; 26(6):790-9. PubMed ID: 6854581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synthesis of 16-(m-chlorophenoxy)-17, 18, 19, 20-tetranor-prostaglandin F2 alpha].
    Liu ZY; Wu XR; He XC
    Yao Xue Xue Bao; 1985 Feb; 20(2):140-2. PubMed ID: 4036619
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
    Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2 alpha analogue.
    Stjernschantz J; Selén G; Sjöquist B; Resul B
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():513-8. PubMed ID: 7732899
    [No Abstract]   [Full Text] [Related]  

  • 33. Functional luteolysis in the pseudopregnant rat: effects of prostaglandin F2 alpha and 16-aryloxy prostaglandin F2 alpha in vitro.
    Hall AK; Robinson J
    J Endocrinol; 1979 Apr; 81(1):157-65. PubMed ID: 469456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological properties of 16(S)-amino-PGF2 alpha methyl ester.
    Ambrus G; Cseh G; Tóth-Sarudy E
    Prostaglandins; 1985 Feb; 29(2):303-12. PubMed ID: 3856905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
    Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased conception rate in dairy cows after early post partum administration of prostaglandin F2 alpha THAM.
    Young IM; Anderson DB; Plenderleith RW
    Vet Rec; 1984 Oct; 115(17):429-31. PubMed ID: 6506431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
    Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic use of prostaglandin F2 alpha.
    Rudd R; Kopcha M
    J Am Vet Med Assoc; 1982 Nov; 181(9):932-4. PubMed ID: 7141997
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of the monkey corpus luteum with 15-methyl prostaglandins.
    Wilks JW
    Prostaglandins; 1980 Nov; 20(5):793-805. PubMed ID: 7465867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular relaxing activity and stability studies of 10,10-difluoro-13,14-dehydroprostacyclin.
    Hatano Y; Kohli JD; Goldberg LI; Fried J; Mehrotra MM
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6846-50. PubMed ID: 7005902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.